Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection
about
Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis.Trans-species communication in the Mycobacterium tuberculosis-infected macrophageThe Carbonic Anhydrase Inhibitor Ethoxzolamide Inhibits the Mycobacterium tuberculosis PhoPR Regulon and Esx-1 Secretion and Attenuates Virulence.Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo.Temporal and intrinsic factors of rifampicin tolerance in mycobacteria.The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage.Defining heterogeneity within bacterial populations via single cell approaches."The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.The ins and outs of the Mycobacterium tuberculosis-containing vacuole.Mycobacterium tuberculosis: Readouts of Bacterial Fitness and the Environment Within the Phagosome.Mycobacterium tuberculosis infection modulates adipose tissue biology.Protective immunity against tuberculosis: what does it look like and how do we find it?A Parallel Adder Coordinates Mycobacterial Cell-Cycle Progression and Cell-Size Homeostasis in the Context of Asymmetric Growth and Organization.Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes.Stable Regulation of Cell Cycle Events in Mycobacteria: Insights From Inherently Heterogeneous Bacterial Populations.Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny.Impact of immunopathology on the antituberculous activity of pyrazinamide
P2860
Q33842523-0FA0BA27-6FBD-43F5-9F20-0F5F75E5FF2FQ35117081-6A6883F5-A8C9-4799-AE82-7CE1E3F06EAAQ35859939-327677D1-43A9-42D5-9C28-7E4F4DAB05C1Q36863134-66287BDB-5127-4363-A494-D20835C07573Q37126903-1619E3FF-1F49-4B4A-9BF8-9CD976CCA987Q37594360-191EB692-962B-48D3-A4A8-1B4A958357E3Q38858511-FF754D8B-460B-452E-B4EF-8A3429A2A3BEQ40213126-CE5CD0E3-A06C-4034-8103-F241E24ADDDAQ41566686-4E13B5D0-913A-4A48-8F32-D82934D90D1BQ41653430-8CEF8A74-BC94-426C-BB2F-011A4C689B2AQ47109234-EFDFAEBE-6A4D-4F16-9C29-BE838E4D39BFQ47159329-5D3BADA9-E007-4DA7-90BD-AB0E57401378Q47177782-543041C9-66DB-4616-89C0-807ECF378B77Q47988525-92D49DC2-70F8-4CDA-ABFD-7F955FCBE126Q52721489-CC3F286E-C018-4201-8613-BB76A7375453Q54263042-BC1E4BE2-0DFF-4EB4-92C8-505A039EBB5DQ58799356-3FCD6FB4-1EC4-41FF-B276-BF93076E17FB
P2860
Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Exploitation of Mycobacterium ...... cination at sites of infection
@ast
Exploitation of Mycobacterium ...... cination at sites of infection
@en
Exploitation of Mycobacterium ...... cination at sites of infection
@nl
type
label
Exploitation of Mycobacterium ...... cination at sites of infection
@ast
Exploitation of Mycobacterium ...... cination at sites of infection
@en
Exploitation of Mycobacterium ...... cination at sites of infection
@nl
prefLabel
Exploitation of Mycobacterium ...... cination at sites of infection
@ast
Exploitation of Mycobacterium ...... cination at sites of infection
@en
Exploitation of Mycobacterium ...... cination at sites of infection
@nl
P2093
P2860
P3181
P1433
P1476
Exploitation of Mycobacterium ...... cination at sites of infection
@en
P2093
Bree B Aldridge
Neelima Sukumar
Shumin Tan
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1004394
P407
P577
2014-09-01T00:00:00Z